1. Market Research
  2. > Therapy Industry

Immunotherapy Industry, September 2016 Market Reports from Top Publishers

You might be interested in: Therapy, Oncology, Bladder Cancer, Cancer, Ovarian Cancer, Breast Cancer, Prostate Cancer, Respiratory Treatment, Colorectal Cancer, Diabetes, Nuclear Medicine, Pancreatic Cancer, Renal Cancer, Blood Disease, Brain Cancer, Lymphoma, Respiratory Disease, Transdermal Delivery, Allergy Immunotherapy, Anti-Infective.


 
1-10 of 68 reports for Immunotherapy

Purchase Reports From Reputable Market Research Publishers

Cancer Immunotherapy Market by Type, Application, End User - Global Forecast to 2021

Cancer Immunotherapy Market by Type, Application, End User - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global cancer immunotherapy market is expected to reach USD 119.39 billion by 2021 from USD 61.97 billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Factors such as increasing incidence of cancer, ...

Cancer Immunotherapy: Analytical Tool

Cancer Immunotherapy: Analytical Tool

  • $ 13 125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

T-Cell Immunotherapy for Cancer -  Pipeline Analysis

T-Cell Immunotherapy for Cancer - Pipeline Analysis

  • $ 1 500
  • Industry report
  • August 2016
  • by RNCOS

Cancer is a leading cause of death worldwide. According to GLOBOCAN 2012, the incidence of cancer is expected to increase from 14 Million in 2012 to approximately 21 Million by 2030. Although conventional ...

Genital Herpes - Pipeline Review, H2 2016

Genital Herpes - Pipeline Review, H2 2016

  • $ 2 000
  • Company report
  • August 2016
  • by Global Markets Direct

Genital Herpes - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Genital Herpes - Pipeline Review, H2 2016’, provides an overview of the Genital Herpes pipeline landscape. The report provides ...

Immunotherapy in Oncology: Drug Pathway Analyzer

Immunotherapy in Oncology: Drug Pathway Analyzer

  • $ 4 410
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 1183 immunotherapy drugs known to affect more than 237 specific intracellular signaling pathways for the ...

Immunotherapy in Oncology Drug Pipeline Update

Immunotherapy in Oncology Drug Pipeline Update

  • $ 4 410
  • Company report
  • August 2016
  • by Bioseeker

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update

  • $ 2 700
  • Industry report
  • August 2016
  • by Bioseeker

BioSeeker’s Targeting Immune Checkpoints in Cancer Immunotherapy: Drug Pipeline Update is the most up to date and comprehensive pipeline review and competitive assessment you can get on this hot and ...

Human Papillomavirus Protein E6 (E6) - Pipeline Review, H2 2016

Human Papillomavirus Protein E6 (E6) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Human Papillomavirus Protein E6 (E6) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Human Papillomavirus Protein E6 (E6) - Pipeline Review, H2 2016’, provides in depth analysis on Human ...

GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates , Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor  T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint

GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates , Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint

  • $ 3 800
  • Industry report
  • July 2016
  • by Kelly Scientific Publications

This report provides a comprehensive overview of the size of cancer immunotherapy market, the segmentation of the market, key players and the vast potential of therapies that are in clinical trials. Oncologic ...

T-cell Immunotherapy: Clinical Trial Tracker

T-cell Immunotherapy: Clinical Trial Tracker

  • $ 949
  • Industry report
  • July 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION After years of research tracing back to the 18th century, a gamut of novel therapies namely, CAR-T, TCR and TIL therapies, have finally reached a point of maturity. These promising therapeutic ...

About 4 600 reports for Immunotherapy

Download Unlimited Documents from Trusted Public Sources

Car-T - Company Report, 2016

  • January 2016
    135 pages
  • Immunotherapy  

    Therapy  

    Cancer  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.